Seeing Is Believing
Currently out of the existing stock ratings of Suraj Kalia, 103 are a BUY (69.59%), 20 are a HOLD (13.51%), 25 are a SELL (16.89%).
Analyst Suraj Kalia, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 47.78% that have a potential upside of 35.65% achieved within 172 days.
Suraj Kalia’s has documented 335 price targets and ratings displayed on 31 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TMDX, TransMedics Group at 03-Dec-2024.
Analyst best performing recommendations are on ISR (ISORAY).
The best stock recommendation documented was for ATRC (ATRICURE) at 4/28/2021. The price target of $75 was fulfilled within 1 day with a profit of $5.15 (7.37%) receiving and performance score of 73.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$388
$6.98 (1.83%)
$355
2 years 1 months 19 days ago
(02-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Hold
$380
$-1.02 (-0.27%)
$235
2 years 1 months 19 days ago
(02-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Hold
$380
$-1.02 (-0.27%)
$350
2 years 1 months 20 days ago
(01-Nov-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy
$300
$-81.02 (-21.26%)
$425
2 years 2 months 9 days ago
(12-Oct-2022)
1/2 (50%)
$57.23 (23.57%)
20
Sell
$235
$-146.02 (-38.32%)
$275
2 years 5 months 6 days ago
(15-Jul-2022)
6/8 (75%)
$-33.23 (-12.39%)
142
Which stock is Suraj Kalia is most bullish on?
Which stock is Suraj Kalia is most reserved on?
What Year was the first public recommendation made by Suraj Kalia?